Search - tctmd.com

Displaying 1 - 20 of 169

Sort: Relevancy | Date

Presentation TCT 2024

TCT 825: Hemodynamic Valve Deterioration in Under- vs Over-Expanded Balloon Expandable Transcatheter Aortic Valves

Presenter: Tyler Andrews

October 29, 2024

Presentation TCT 2024

TCT 955: Pathology of Non-calcific Structural Valve Deterioration in Transcatheter and Surgical Aortic Bioprosthesis

Presenter: Yu Sato

October 28, 2024

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

Presentation TCT 2024

TCT 205: Automatic Characterization of Post-TAVR CT for the Evaluation of Valve Deterioration

Presenter: Pablo Juan-Salvadores

October 27, 2024

News Daily News

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Caitlin E. Cox

June 21, 2024

News Conference News NY Valves 2024

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

Todd Neale

June 14, 2024

News Conference News EuroPCR 2024

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Shelley Wood

May 15, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Conference News ACC 2024

SMART: Small Aortic Annuli May Fare Best With Self-Expandable Valve

L.A. McKeown

April 07, 2024

News Conference News STS 2024

SAVR After Failed TAVI on the Rise, With High Mortality

Yael L. Maxwell

February 05, 2024

News Conference News PCR London Valves 2023

Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge

Shelley Wood

November 27, 2023

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

News Conference News TCT 2023

CLASP IID at 1 Year: Good Results With Both Pascal, MitraClip for Mitral TEER

Todd Neale

October 26, 2023

Presentation TCT 2023

TCT 59: Surgical Aortic Valve Deterioration: Time to redo-SAVR in Trifecta versus non-Trifecta Valves

Presenter: Mazhed Kheyrbek

October 26, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

News Daily News

Abbott to Stop Making Trifecta Surgical Aortic Valves

Michael O'Riordan

July 31, 2023

News Conference News EuroPCR 2023

Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics

Michael O'Riordan

May 17, 2023

News Conference News THT 2023

TEER or VAD/Transplant in the Advanced HF Patient With MR?

Shelley Wood

March 20, 2023

News Conference News CRT 2023

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

Yael L. Maxwell

March 03, 2023

News Daily News

FDA Alert: Possible Early Deterioration of Abbott Trifecta SAVR Valves

Todd Neale

February 27, 2023

Advertisement

TCT 825: Hemodynamic Valve Deterioration in Under- vs Over-Expanded Balloon Expandable Transcatheter Aortic Valves

TCT 955: Pathology of Non-calcific Structural Valve Deterioration in Transcatheter and Surgical Aortic Bioprosthesis

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

TCT 205: Automatic Characterization of Post-TAVR CT for the Evaluation of Valve Deterioration

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

SMART: Small Aortic Annuli May Fare Best With Self-Expandable Valve

SAVR After Failed TAVI on the Rise, With High Mortality

Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

CLASP IID at 1 Year: Good Results With Both Pascal, MitraClip for Mitral TEER

TCT 59: Surgical Aortic Valve Deterioration: Time to redo-SAVR in Trifecta versus non-Trifecta Valves

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Abbott to Stop Making Trifecta Surgical Aortic Valves

Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics

TEER or VAD/Transplant in the Advanced HF Patient With MR?

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

FDA Alert: Possible Early Deterioration of Abbott Trifecta SAVR Valves

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content